- 询价
- WYTSCI
- 进口
- WT-SE-A30403
- 2025年07月09日
企业认证
相关产品推荐更多 >
![[2H4]-柳氮磺吡啶](https://img1.dxycdn.com/p/s14/2025/0410/195/0690020283970710191.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
冷冻-20℃
- 保质期：
咨询
- 英文名：
CB1 antagonist 2
- 库存：
100+
- 供应商：
上海维亦特生物科技有限公司
- CAS号：
614726-85-1
分子式：C17H12Cl3N3O
分子量：380.66
别名： AM4113
溶解度：
DMSO: 1.9 mg/mL (4.99 mM),
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods Evaluating Cannabinoid and Endocannabinoid Effects on Gastrointestinal Functions
(Δ9 -THC) and well-studied representatives of other classes of exogenous cannabinoid CB1 /CB2 receptor agonists inhibit gastrointestinal motility, peristalsis, defecation, and secretions via cannabinoid CB1 receptors since the CB1 (SR141716
Overview of Receptor Allosterism
Figure 1.21.2 Effect of: (A ) negative allosteric modulator, (B ) positive allosteric modulator, or (C ) a competitive antagonist on orthosteric ligand‐receptor occupancy (ρA ). For all the simulations, p K
or competitive antagonist that binds to the endogenous agonist binding site. Because of the complex nature of allosteric phenomena, the detection and quantification of their effects on orthosteric ligand binding relies on the use of both equilibrium and non
技术资料暂无技术资料 索取技术资料
